N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.Cholinergics + Sigma 1 receptor
Correct, cognition and neurogenesis.
but in other type of meds there is Opipramol (selective) and Fluvoxamine
Opipramol - Wikipedia
en.wikipedia.org
Fluvoxamine - Wikipedia
en.wikipedia.org
Oof, a TCA. Fluvoxamine i'm also looking at but would be combining an SSRI with ache inhibitor, want a second option on ACHE inhibitor. Any idea on if you can combine 2 sigma-1 agonists?
I have biases against ache inhibitors after reading too many toxicology papers on low level organophosphate exposure in agricultural workers and the increase in neurodegeneration. This may very well not carry over to non-covalent inhibitors, but the fear has been planted in me.
Make sense, every exogenous ligand has it's side effects just about. Could you provide a link? It can't be all that bad.
Just found this: https://pubmed.ncbi.nlm.nih.gov/32798937/
I like this more than pure epidemiological stuff because they not only tie risk to organophosphate exposure, but they look into paroxonase1 (PON1) functional polymorphisms. PON1 breaks down organophosphates, so the finding that the slow metabolism phenotypes increase Parkinson's risk when around organophosphates strengthens the argument that they are causitive.
I've only found one single study on this:
Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairmentsizo
Bluelighter
izo
Bluelighter
plumbus-nine
Bluelighter
But there's certainly something about sigma, just look @ DXM or ibogaine, for example.